402 related articles for article (PubMed ID: 9721727)
1. Nociceptin (ORL-1) and mu-opioid receptors mediate mitogen-activated protein kinase activation in CHO cells through a Gi-coupled signaling pathway: evidence for distinct mechanisms of agonist-mediated desensitization.
Hawes BE; Fried S; Yao X; Weig B; Graziano MP
J Neurochem; 1998 Sep; 71(3):1024-33. PubMed ID: 9721727
[TBL] [Abstract][Full Text] [Related]
2. Mu-opioid-induced desensitization of opioid receptor-like 1 and mu-opioid receptors: differential intracellular signaling determines receptor sensitivity.
Mandyam CD; Thakker DR; Standifer KM
J Pharmacol Exp Ther; 2003 Sep; 306(3):965-72. PubMed ID: 12750434
[TBL] [Abstract][Full Text] [Related]
3. Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and mu opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk.
Mandyam CD; Thakker DR; Christensen JL; Standifer KM
J Pharmacol Exp Ther; 2002 Aug; 302(2):502-9. PubMed ID: 12130708
[TBL] [Abstract][Full Text] [Related]
4. Orphanin FQ/nociceptin potentiates [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin-Induced mu-opioid receptor phosphorylation.
Ozsoy HZ; Thakker DR; Standifer KM
Mol Pharmacol; 2005 Aug; 68(2):447-56. PubMed ID: 15890842
[TBL] [Abstract][Full Text] [Related]
5. Induction of G protein-coupled receptor kinases 2 and 3 contributes to the cross-talk between mu and ORL1 receptors following prolonged agonist exposure.
Thakker DR; Standifer KM
Neuropharmacology; 2002 Nov; 43(6):979-90. PubMed ID: 12423667
[TBL] [Abstract][Full Text] [Related]
6. Nociceptin/orphanin FQ activates mitogen-activated protein kinase in Chinese hamster ovary cells expressing opioid receptor-like receptor.
Lou LG; Zhang Z; Ma L; Pei G
J Neurochem; 1998 Mar; 70(3):1316-22. PubMed ID: 9489755
[TBL] [Abstract][Full Text] [Related]
7. Modulation of μ-opioid receptor signaling by RGS19 in SH-SY5Y cells.
Wang Q; Traynor JR
Mol Pharmacol; 2013 Feb; 83(2):512-20. PubMed ID: 23197645
[TBL] [Abstract][Full Text] [Related]
8. Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors.
Lutfy K; Eitan S; Bryant CD; Yang YC; Saliminejad N; Walwyn W; Kieffer BL; Takeshima H; Carroll FI; Maidment NT; Evans CJ
J Neurosci; 2003 Nov; 23(32):10331-7. PubMed ID: 14614092
[TBL] [Abstract][Full Text] [Related]
9. Nociceptin/orphanin FQ activates protein kinase C, and this effect is mediated through phospholipase C/Ca2+ pathway.
Lou LG; Ma L; Pei G
Biochem Biophys Res Commun; 1997 Nov; 240(2):304-8. PubMed ID: 9388473
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of inhibitory effects of postsynaptic opioid and cannabinoid receptors on calcium currents in neonatal rat nucleus tractus solitarius.
Endoh T
Br J Pharmacol; 2006 Feb; 147(4):391-401. PubMed ID: 16402042
[TBL] [Abstract][Full Text] [Related]
11. Regulation of c-Jun N-terminal kinase by the ORL(1) receptor through multiple G proteins.
Chan AS; Wong YH
J Pharmacol Exp Ther; 2000 Dec; 295(3):1094-100. PubMed ID: 11082445
[TBL] [Abstract][Full Text] [Related]
12. Orphanin FQ-ORL-1 regulation of reproduction and reproductive behavior in the female.
Sinchak K; Dalhousay L; Sanathara N
Vitam Horm; 2015; 97():187-221. PubMed ID: 25677773
[TBL] [Abstract][Full Text] [Related]
13. Recognition and activation of the opioid receptor-like ORL 1 receptor by nociceptin, nociceptin analogs and opioids.
Butour JL; Moisand C; Mazarguil H; Mollereau C; Meunier JC
Eur J Pharmacol; 1997 Feb; 321(1):97-103. PubMed ID: 9083791
[TBL] [Abstract][Full Text] [Related]
14. Differential antagonism by naloxone benzoylhydrazone of the activation of inward rectifying K+ channels by nociceptin and a mu-opioid in rat periaqueductal grey slices.
Chiou LC
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jun; 363(6):583-9. PubMed ID: 11414652
[TBL] [Abstract][Full Text] [Related]
15. Helix-constrained nociceptin peptides are potent agonists and antagonists of ORL-1 and nociception.
Lohman RJ; Harrison RS; Ruiz-Gómez G; Hoang HN; Shepherd NE; Chow S; Hill TA; Madala PK; Fairlie DP
Vitam Horm; 2015; 97():1-55. PubMed ID: 25677767
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological properties of TRK-820 on cloned mu-, delta- and kappa-opioid receptors and nociceptin receptor.
Seki T; Awamura S; Kimura C; Ide S; Sakano K; Minami M; Nagase H; Satoh M
Eur J Pharmacol; 1999 Jul; 376(1-2):159-67. PubMed ID: 10440101
[TBL] [Abstract][Full Text] [Related]
17. Distinct pathways of Gi- and Gq-mediated mitogen-activated protein kinase activation.
Hawes BE; van Biesen T; Koch WJ; Luttrell LM; Lefkowitz RJ
J Biol Chem; 1995 Jul; 270(29):17148-53. PubMed ID: 7615510
[TBL] [Abstract][Full Text] [Related]
18. Opioid modulation of extracellular signal-regulated protein kinase activity is ras-dependent and involves Gbetagamma subunits.
Belcheva MM; Vogel Z; Ignatova E; Avidor-Reiss T; Zippel R; Levy R; Young EC; Barg J; Coscia CJ
J Neurochem; 1998 Feb; 70(2):635-45. PubMed ID: 9453557
[TBL] [Abstract][Full Text] [Related]
19. Nociceptin/orphanin FQ stimulates extracellular acidification and desensitization of the response involves protein kinase C.
Pei G; Ling K; Pu L; Cunningham MD; Ma L
FEBS Lett; 1997 Jul; 412(1):253-6. PubMed ID: 9257731
[TBL] [Abstract][Full Text] [Related]
20. The melanin-concentrating hormone receptor couples to multiple G proteins to activate diverse intracellular signaling pathways.
Hawes BE; Kil E; Green B; O'Neill K; Fried S; Graziano MP
Endocrinology; 2000 Dec; 141(12):4524-32. PubMed ID: 11108264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
